Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 159
Aptamer sequence: GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU
Target unique ID: P03372
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_155 aptER-3 Protein ESR1_HUMAN 30 nM 12 mM HEPES/pH 7.6, 150 mM NaCl, and 10 mM MgCl2 24588102
Structure information of aptamer
Aptamer Sequence: GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU
The optimal secondary structure in dot-bracket notation: (((...((((((((..((...))..))........))))))..)))........
The centroid secondary structure in dot-bracket notation: (((...((((((((..((...))..))........))))))..)))........
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_155 Description aptER-3
Aptamer chemistry RNA Length 54 nt
GC content 64.8% Molecular weight 17,765.55 Da
Molarity of 1 μg/μl solution 56.29 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU
Applications Effectively inhibited ER-mediated transcriptional activation in a breast cancer cell line
Target information
Type Detail Type Detail
Uniprot ID P03372 Protein name Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
Gene name(s) ESR1 ESR NR3A1 Organism Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
Status reviewed in uniprot database Length 595
Mass 66,216 Activity regulation N/A
Involvement in disease Estrogen resistance (ESTRR) Catalytic activity N/A
PDB ID(s)
1A52;1ERE;1ERR;1G50;1GWQ;1GWR;1HCP;1HCQ;1L2I;1PCG;1QKT;1QKU;1R5K;1SJ0;1UOM;1X7E;1X7R;1XP1;1XP6;1XP9;1XPC;1XQC;1YIM;1YIN;1ZKY;2AYR;2B1V;2B1Z;2B23;2BJ4;2FAI;2G44;2G5O;2I0J;2IOG;2IOK;2JF9;2JFA;2LLO;2LLQ;2OCF;2OUZ;2P15;2POG;2Q6J;2Q70;2QA6;2QA8;2QAB;2QE4;2QGT;2QGW;2QH6;2QR9;2QSE;2QXM;2QXS;2QZO;2R6W;2R6Y;2YAT;2YJA;3CBM;3CBO;3CBP;3DT3;3ERD;3ERT;3HLV;3HM1;3L03;3OS8;3OS9;3OSA;3Q95;3UU7;3UUA;3UUC;3UUD;4AA6;4DMA;4IU7;4IUI;4IV2;4IV4;4IVW;4IVY;4IW6;4IW8;4IWC;4IWF;4JC3;4JDD;4MG5;4MG6;4MG7;4MG8;4MG9;4MGA;4MGB;4MGC;4MGD;4O6F;4PP6;4PPP;4PPS;4PXM;4Q13;4Q50;4TUZ;4TV1;4XI3;4ZN7;4ZN9;4ZNH;4ZNS;4ZNT;4ZNU;4ZNV;4ZNW;5AAU;5AAV;5ACC;5AK2;5DI7;5DID;5DIE;5DIG;5DK9;5DKB;5DKE;5DKG;5DKS;5DL4;5DLR;5DMC;5DMF;5DP0;5DRJ;5DRM;5DTV;5DU5;5DUE;5DUG;5DUH;5DVS;5DVV;5DWE;5DWG;5DWI;5DWJ;5DX3;5DXB;5DXE;5DXG;5DXK;5DXM;5DXP;5DXQ;5DXR;5DY8;5DYB;5DYD;5DZ0;5DZ1;5DZ3;5DZH;5DZI;5E0W;5E0X;5E14;5E15;5E19;5E1C;5EGV;5EHJ;5EI1;5EIT;5FQP;5FQR;5FQS;5FQT;5FQV;5GS4;5GTR;5HYR;5JMM;5KCC;5KCD;5KCE;5KCF;5KCT;5KCU;5KCW;5KD9;5KR9;5KRA;5KRC;5KRF;5KRH;5KRI;5KRJ;5KRK;5KRL;5KRM;5KRO;5N10;5T0X;5T1Z;5T92;5T97;5TLD;5TLF;5TLG;5TLL;5TLM;5TLO;5TLP;5TLT;5TLU;5TLV;5TLX;5TLY;5TM1;5TM2;5TM3;5TM4;5TM5;5TM6;5TM7;5TM8;5TM9;5TML;5TMM;5TMO;5TMQ;5TMR;5TMS;5TMT;5TMU;5TMV;5TMW;5TMZ;5TN1;5TN3;5TN4;5TN5;5TN6;5TN7;5TN8;5TN9;5TNB;5U2B;5U2D;5UFW;5UFX;5W9C;5W9D;5WGD;5WGQ;6B0F;6C42;6CBZ;6CHW;6CHZ;6CZN;6D0F;6DF6;6DFN;6HHP;6HKB;6HKF;6HMU;6IAR;6OWC;6PET;6PFM;6PIT;6PSJ;6SBO;6SQ0;6SUO;6TJM;6TL3;6V87;6V8T;6VGH;6VIG;6VJD;6VMU;6VPF;6VPK;6VVP;6WOK;6ZOQ;6ZOR;6ZOS;7B9M;7B9R;7B9T;7BA3;7BA5;7BA6;7BA7;7BA8;7BA9;7BAA;7BAB;7JHD;7KBS;7KCA;7KCD;7MSA;7NDO;7NEL;7NFB;7NFW;7NIZ;7RRX;7RRY;7RRZ;7RS0;7RS1;7RS2;7RS3;7RS4;7RS7;7RS8;7RS9;7TE7;7UJ7;
Function Nuclear hormone receptor.
Activity data
Interaction ID 159
Target type Protein
Target unique ID P03372
Activity 30 nM
Binding Conditions/Buffer

12 mM HEPES/pH 7.6, 150 mM NaCl, and 10 mM MgCl2

Assay

Binding curves of the aptamers for ERa determined using filter-binding assays. The apparent Kd determined from binding curves is shown next to the title of each curve. Each experiment was repeated at least three times and the standard deviation was shown as error bars

PubMed ID 24588102
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_416 RNA GGACCUCGGCGAAAGCCGGUAACGCCACAAGUCGGAGGGUAAGAUCUGACAGGAACUGGGUGACGGAGGUUAGGUGC 54.55%
Apta_154 RNA ACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAAGU 53.70%
Apta_888 DNA GGCGACCCCCGGGCTACCAGACAATGTACGCAGCAAGAGTGACGGTCGTACCTCGGAGTC 53.33%
Apta_61 DNA AGCAGCACAGAGGTCAGATGGCAGGTAAGCAGGCGGCTCACAAAACCATTCGCATGCGGCCCTATGCGTGCTACCGTGAA 52.50%
Apta_383 RNA GGCGUGACCUGAUGAGUCACGCUAAGGAGGAUUUCCGAAAGCGGCUACGGUCCGCCAGUGUUACGAAACGUUCCC 52.00%
Apta_585 DNA GATCGAGGGCAGCGATAGCTGGGCTAATAAGGTTAGCCCCATCGGTC 51.85%
Apta_1121 RNA GACAGCGUGCCUAGAAGUCCAAGCUUAAAUAACCACGCUCGACAAGC 51.85%
Apta_645 RNA CUGGACGACGGGGACGCCACUGGACUAGGUAAGCCAGGACCGUACGUCGGGAGCCGUCAGAAUA 51.56%
Apta_766 RNA GGUUACCAGCCUUCACUGCGGACGGACAGAGAGUGCAACCUGCCGUGCCGCACCACGGUCGGUCACAC 51.47%
Apta_574 RNA AUGAAAAGGGCUGGCGAGACAUAUCCGCUGGGCAAUCAGAUUCGGAGCCGCACCACCCUCGAAGUAGACA 51.43%
Apta_52 RNA ACUGUCCUCCCUUCAGAGAGCGCGGGACCCUUAACUUGGGGCCCACGAACAGCUUCAGUUCCGUCUCGGCGU 51.39%
Apta_898 DNA ATACGGGAGCCAACACCAACAAAACTAGCAAATTAGAGCCGTATCGGAGCCTATAGAGCAGGTGTGACGGAT 51.39%
Apta_447 RNA ACGCUCAACGAGCCAGGAACAUCGACGUCAGCAAACGCGAGCGCAACCAGUAACACC 50.88%
Apta_526 DNA ATACGGGAGCCAACACCAAGTAACACACGCGGACCAGAAATACATCCCCCCGTAGAGCAGGTGTGACGGAT 50.70%
Apta_153 RNA CCACAGUUCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAAC 50.00%
Apta_290 DNA GAACTCACCGGGAAGAAGCCCGTTCCGTCACAGACATGTT 50.00%
Apta_340 DNA TACTCAGGGCACTGCAAGCAATTGTGGTCCCAATGGGCTGAGTA 50.00%
Apta_488 DNA CGACCAGGGTGGGAGGGGGACGGGCTGGCGGCGCGCGGTAATG 50.00%
Apta_514 DNA ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG 50.00%
Apta_690 RNA GGGCGAAUUCCCGAGGACCAAAUAGUACCACCCGGGAAAACAGCUAAUGCCGAAACGGAGAUUUUUUCUGCAGAAGCU 50.00%